Patents by Inventor Amina Laanan

Amina Laanan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10441648
    Abstract: Immunogenic compositions comprising an M72 related antigen, wherein the conductivity of the composition is 13 mS/cm or lower, or the concentration of salts of the composition is 130 mM or lower, and their use in medicine, are provided.
    Type: Grant
    Filed: July 6, 2017
    Date of Patent: October 15, 2019
    Assignee: GlaxoSmithKline Biologicals SA
    Inventors: Stéphane André Georges Godart, Amina Laanan, Dominique Ingrid Lemoine
  • Publication number: 20190183998
    Abstract: Immunogenic compositions comprising an M72 related antigen, wherein the conductivity of the composition is 13 mS/cm or lower, or the concentration of salts of the composition is 130 mM or lower, and their use in medicine, are provided.
    Type: Application
    Filed: February 8, 2019
    Publication date: June 20, 2019
    Applicant: GLAXOSMITHKLINE BIOLOGICALS, S.A.
    Inventors: Stephane Andre Georges GODART, Amina LAANAN, Dominique Ingrid LEMOINE
  • Publication number: 20180071378
    Abstract: Immunogenic compositions comprising an M72 related antigen, wherein the conductivity of the composition is 13 mS/cm or lower, or the concentration of salts of the composition is 130 mM or lower, and their use in medicine, are provided.
    Type: Application
    Filed: July 6, 2017
    Publication date: March 15, 2018
    Applicant: GLAXOSMITHKLINE BIOLOGICALS, SA
    Inventors: Stéphane André Georges GODART, Amina LAANAN, Dominique Ingrid LEMOINE
  • Patent number: 9730992
    Abstract: Immunogenic compositions comprising an M72 related antigen, wherein the conductivity of the composition is 13 mS/cm or lower, or the concentration of salts of the composition is 130 mM or lower, and their use in medicine, are provided.
    Type: Grant
    Filed: December 14, 2011
    Date of Patent: August 15, 2017
    Assignee: GLAXOSMITHKLINE BIOLOGICALS S.A.
    Inventors: Stéphane André Georges Godart, Amina Laanan, Dominique Ingrid Lemoine
  • Publication number: 20160220656
    Abstract: Immunogenic compositions comprising an Rv1196 related antigen, wherein the conductivity of the composition is 13 mS/cm or lower, or the concentration of salts of the composition is 130 mM or lower, and their use in medicine, are provided.
    Type: Application
    Filed: April 18, 2016
    Publication date: August 4, 2016
    Inventors: Stephane Andre Georges GODART, Amina LAANAN, Dominique Ingrid LEMOINE
  • Patent number: 9352030
    Abstract: Immunogenic compositions comprising an Rv1196 related antigen, wherein the conductivity of the composition is 13 mS/cm or lower, or the concentration of salts of the composition is 130 mM or lower, and their use in medicine, are provided.
    Type: Grant
    Filed: December 14, 2011
    Date of Patent: May 31, 2016
    Assignee: GlaxoSmithKline Biologicals, S.A.
    Inventors: Stéphane André Georges Godart, Amina Laanan, Dominique Ingrid Lemoine
  • Publication number: 20140234424
    Abstract: Methods and processes for the purification of PRAME are provided. In particular, methods for reducing the aggregation of PRAME during a diluent exchange from diluent A to diluent B comprising: (i) adding a polyanionic compound to diluent A prior to or contemporaneously with the exchange; and (ii) exchanging protein from diluent A to diluent B are provided. Compositions produced by the method are also provided.
    Type: Application
    Filed: July 20, 2012
    Publication date: August 21, 2014
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Olivier C Germay, Stephane Andre Godart, Pol Guy Harvengt, Amina Laanan, Olivier Patrick Le Bussy, Dominique Ingrid Lemoine, Leonard Dode
  • Publication number: 20130287809
    Abstract: Immunogenic compositions comprising an Rv1196 related antigen, wherein the conductivity of the composition is 13 mS/cm or lower, or the concentration of salts of the composition is 130 mM or lower, and their use in medicine, are provided.
    Type: Application
    Filed: December 14, 2011
    Publication date: October 31, 2013
    Applicant: GlaxoSmithKline Biologicals s.a.
    Inventors: Stéphane André Georges Godart, Amina Laanan, Dominique Ingrid Lemoine
  • Publication number: 20130280289
    Abstract: Immunogenic compositions comprising an M72 related antigen, wherein the conductivity of the composition is 13 mS/cm or lower, or the concentration of salts of the composition is 130 mM or lower, and their use in medicine, are provided.
    Type: Application
    Filed: December 14, 2011
    Publication date: October 24, 2013
    Applicant: GlaxoSmithKline Biologicals s.a.
    Inventors: Stéphane André Georges Godart, Amina Laanan, Dominique Ingrid Lemoine